Literature DB >> 11483801

Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial.

D L O'Connor1, R Hall, D Adamkin, N Auestad, M Castillo, W E Connor, S L Connor, K Fitzgerald, S Groh-Wargo, E E Hartmann, J Jacobs, J Janowsky, A Lucas, D Margeson, P Mena, M Neuringer, M Nesin, L Singer, T Stephenson, J Szabo, V Zemon.   

Abstract

OBJECTIVES: A randomized, masked, controlled trial was conducted to assess effects of supplementing premature infant formulas with oils containing the long-chain polyunsaturated fatty acids, arachidonic acid (AA; 20:4 n6), and docosahexaenoic acid (DHA; 22:6 n3) on growth, visual acuity, and multiple indices of development.
METHODS: Infants (N = 470) with birth weights 750 to 1800 g were assigned within 72 hours of the first enteral feeding to 1 of 3 formula groups with or without long-chain polyunsaturated fatty acids: 1) control (N = 144), 2) AA+DHA from fish/fungal oil (N = 140), and 3) AA+DHA from egg-derived triglyceride (egg-TG)/fish oil (N = 143). Infants were fed human milk and/or Similac Special Care with or without 0.42% AA and 0.26% DHA to term corrected age (CA), then fed human milk or NeoSure with or without 0.42% AA and 0.16% DHA to 12 months' CA. Infants fed exclusively human milk to term CA (EHM-T; N = 43) served as a reference.
RESULTS: Visual acuity measured by acuity cards at 2, 4, and 6 months' CA was not different among groups. Visual acuity measured by swept-parameter visual-evoked potentials in a subgroup from 3 sites (45 control, 50 AA+DHA [fish/fungal]; 39 AA+DHA [egg-TG/fish]; and 23 EHM-T) was better in both the AA+DHA (fish/fungal; least square [LS] means [cycle/degree] +/- standard error [SE; octaves] 11.4 +/- 0.1) and AA+DHA (egg-TG/fish; 12.5 +/- 0.1) than control (8.4 +/- 0.1) and closer to that of the EHM-T group (16.0 +/- 0.2) at 6 months' CA. Visual acuity improved from 4 to 6 months' CA in all but the control group. Scores on the Fagan test of novelty preference were greater in AA+DHA (egg-TG/fish; LS means +/- SE, 59.4 +/- 7.7) than AA+DHA (fish/fungal; 57.0 +/- 7.5) and control (57.5 +/- 7.4) at 6 months' CA, but not at 9 months' CA. There were no differences in the Bayley Mental Development Index at 12 months' CA. However, the Bayley motor development index was higher for AA+DHA (fish/fungal; LS means +/- SE, 90.6 +/- 4.4) than control (81.8 +/- 4.3) for infants </=1250 g. When Spanish-speaking infants and twins were excluded from the analyses, the MacArthur Communicative Development Inventory revealed that control infants (LS means +/- SE, 94.1 +/- 2.9) had lower vocabulary comprehension at 14 months' CA than AA+DHA (fish/fungal) infants (100.6 +/- 2.9) or AA+DHA (egg-TG/fish) infants (102.2 +/- 2.8). There were no consistent differences in weight, length, head circumference, or anthropometric gains.
CONCLUSION: These results showed a benefit of supplementing formulas for premature infants with AA and DHA from either a fish/fungal or an egg-TG/fish source from the time of first enteral feeding to 12 months' CA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483801     DOI: 10.1542/peds.108.2.359

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  64 in total

1.  Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition.

Authors:  Ahmad Qawasmi; Angeli Landeros-Weisenberger; James F Leckman; Michael H Bloch
Journal:  Pediatrics       Date:  2012-05-28       Impact factor: 7.124

2.  Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain.

Authors:  David S Grayson; Christopher D Kroenke; Martha Neuringer; Damien A Fair
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

3.  Breastfeeding and long-chain polyunsaturated fatty acid intake in the first 4 post-natal months and infant cognitive development: an observational study.

Authors:  Sarah A Keim; Julie L Daniels; Anna Maria Siega-Riz; Amy H Herring; Nancy Dole; Peter C Scheidt
Journal:  Matern Child Nutr       Date:  2011-05-27       Impact factor: 3.092

4.  n-3 Fatty Acid Supplementation in Mothers, Preterm Infants, and Term Infants and Childhood Psychomotor and Visual Development: A Systematic Review and Meta-Analysis.

Authors:  Masha Shulkin; Laura Pimpin; David Bellinger; Sarah Kranz; Wafaie Fawzi; Christopher Duggan; Dariush Mozaffarian
Journal:  J Nutr       Date:  2018-03-01       Impact factor: 4.798

5.  Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.

Authors:  Sarah A Keim; Kelly M Boone; Mark A Klebanoff; Abigail Norris Turner; Joseph Rausch; Mary Ann Nelin; Lynette K Rogers; Keith Owen Yeates; Leif Nelin; Kelly W Sheppard
Journal:  JAMA Pediatr       Date:  2018-12-01       Impact factor: 16.193

6.  High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant.

Authors:  Cornelius M Smuts; Emily Borod; Jeanette M Peeples; Susan E Carlson
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

7.  n-3, but not n-6 lipid particle uptake requires cell surface anchoring.

Authors:  Faith M Murray-Taylor; Yuan-Yuan Ho; Narumon Densupsoontorn; Chuchun L Chang; Richard J Deckelbaum; Toru Seo
Journal:  Biochem Biophys Res Commun       Date:  2010-01-07       Impact factor: 3.575

8.  Meta-analysis of LCPUFA supplementation of infant formula and visual acuity.

Authors:  Ahmad Qawasmi; Angeli Landeros-Weisenberger; Michael H Bloch
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

Review 9.  Docosahexaenoic acid and visual functioning in preterm infants: a review.

Authors:  Carly Molloy; Lex W Doyle; Maria Makrides; Peter J Anderson
Journal:  Neuropsychol Rev       Date:  2012-10-12       Impact factor: 7.444

10.  Type 1 diabetes compromises plasma arachidonic and docosahexaenoic acids in newborn babies.

Authors:  Kebreab Ghebremeskel; Beverley Thomas; Clara Lowy; Yoeju Min; Michael A Crawford
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.